Genomics England works with the NHS to bring forward the use of genomic healthcare and research in Britain to help people live longer, healthier lives.
Genomics is a ground-breaking area of medicine that uses our unique genetic code to help diagnose, treat and prevent illnesses. Thanks to advanced technology, scientists can now compare many people’s genetic code to make new discoveries that continually improve genomic healthcare.
In 2013, Genomics England and the NHS launched the 100,000 Genomes Project, demonstrating how genomics insights can help doctors across the NHS, and building a foundation for the future by assembling a unique dataset. Genomics England is now supporting the NHS to deliver genomic testing for patients as part of routine healthcare, and providing the health data and technology that researchers need to make new discoveries and create more effective, targeted medicines.
We work with thousands of people – patients, doctors and scientists – to increase our collective knowledge and enable faster and deeper genomic research, to bring genomic healthcare to all who need it.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2013
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Genomics England founded?
Genomics England was founded in 2013.
What industry is Genomics England in?
Genomics England operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Genomics England based?
Genomics England is headquartered in London, United Kingdom.
Find investors for your startup like Genomics England
Gritt sends AI-personalised outreach to each investor — from your Gmail
